Cluster headaches are characterized by extremely painful attacks of severe, recurrent, unilateral headache and so-called autonomic symptoms, e.g., increase tear flow on the same side as the pain.

Preventive treatment with the calcitonin gene-related peptide (CGRP) receptor monoclonal antibody erenumab for 6 weeks was not associated with significant reductions in weekly headache attacks, pain ...

Please provide your email address to receive an email when new articles are posted on . Approximately one in 1,000 people have cluster headaches. Cluster headaches are nicknamed “suicide headaches” ...

Prednisone is a corticosteroid that’s commonly used across a wide range of medical specialties for its anti-inflammatory properties. In neurology, it has emerged as a therapeutic option for the acute ...

Eli Lilly secured federal approval for Emgality, the first migraine treatment approved in the U.S. for decreasing the frequency of episodic cluster headache attacks, the FDA announced June 4. 1.

For almost 13 years, 33-year-old Nikita Rathod endured severe right-sided cluster headaches, widely regarded as one of the ...

Trigeminal autonomic cephalalgias (TACs) are a group of headache disorders characterized, as the name suggests, by autonomic symptoms that accompany the headache. These symptoms commonly include ...

This section describes efficacy outcomes from the published literature that the Committee considered as part of the evidence about this procedure. For more detailed information on the evidence, see ...

In a paper published in the May issue of JAMA, M. S. Robbins, of Weill Cornell Medical College, reviews the diagnosis, prevention, and treatment of primary headaches. In a previous post, I discussed ...

*Refers to the latest 2 years of stltoday.com stories. Cancel anytime. Dear Dr. Roach • Out of the blue, I started with classic cluster headaches about nine years ago. I get one every night between 8 ...